Biotechnology
Technology
Health
Acceleron Pharma
$41.009876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$41.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.03 (0.07%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell XLRN and other stocks, options, ETFs, and crypto commission-free!
About XLRN
Acceleron Pharma Inc. Common Stock, also called Acceleron Pharma, is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Read More Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maneates in June 2003 and is headquartered in Cambridge, MA.
Employees
173
Headquarters
Cambridge, Massachusetts
Founded
2003
Market Cap
2.15B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
388.79K
High Today
$41.70
Low Today
$40.48
Open Price
$41.10
Volume
198.90K
52 Week High
$59.59
52 Week Low
$37.01
Collections
Biotechnology
Technology
Health
Biopharmaceutical
Therapy
Pharmaceutical
2013 IPO
US
Price Paid on Robinhood
0% Lower
Right Now
52 Week Low
$37.01
Average Price Paid
$41.14
52 Week High
$59.59
Analyst Ratings
69%
of 13 ratings
Buy
69%
Hold
31%
Sell
0%
XLRN Earnings
-$0.75
-$0.69
-$0.64
-$0.58
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 1, After Hours